UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Schedule TO
Tender Offer Statement under Section 14(d)(1) or 13(e)(1)
of the Securities Exchange Act of 1934
Natrol, Inc.
(Name of Subject Company (Issuer))
Nutra Acquisition Company, Inc.
and
Plethico Pharmaceuticals Limited
(Names of Filing Persons (Offerors))
Common Stock, $.01 par value per share
(Title of Class of Securities)
638789107
(CUSIP Number of Class
of Securities)
Michael V. Gisser, Esq.
Skadden, Arps, Slate, Meagher & Flom LLP
300 South Grand Avenue
Suite 3400
Los Angeles, California 90071
(213) 687-5000
(Name, Address and Telephone Numbers of Person Authorized
to Receive Notices and Communications on Behalf of Filing Persons)
Copy to:
Steven Spitz
Natrol, Inc.
General Counsel
21411 Prairie Street
Chatsworth, California 91311
(818) 739-6000
CALCULATION OF FILING FEE
|
|
|
Transaction Valuation*
|
|
Amount of Filing Fee*
|
$62,752,553
|
|
$1,927
|
*
|
Estimated solely for purposes of calculating the filing fee in accordance with Rule 0-11 under the Securities Exchange Act of 1934, as amended. The amount of the filing fee is
calculated by multiplying the transaction value by 0.0000307. The transaction value was determined by multiplying the offer price of $4.40 per share by 14,261,944 shares of common stock issued and outstanding (the number of shares represented by
Natrol in the Merger Agreement (as defined herein) to be issued and outstanding as of November 14, 2007).
|
¨
|
Check the box if any part of the fee is offset as provided by Rule 0-11 (a) (2) and identify the filing with which the offsetting fee was previously paid. Identify
the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
|
|
Amount Previously Paid: None
|
|
Filing Party: Not applicable
|
Form or Registration No.: Not applicable
|
|
Date Filed: Not applicable
|
¨
|
Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.
|
Check the appropriate boxes below to designate any transactions to which the statement relates:
þ
|
third-party tender offer subject to Rule 14d-1.
|
¨
|
issuer tender offer subject to Rule 13e-4.
|
¨
|
going-private transaction subject to Rule 13e-3.
|
¨
|
amendment to Schedule 13D under Rule 13d-2.
|
Check the following
box if the filing is a final amendment reporting the results of the tender offer:
¨
This Tender Offer Statement on Schedule TO (this
Schedule TO
) relates to the offer by
Nutra Acquisition Company, Inc. (
Purchaser
) and Plethico Pharmaceuticals Limited (
Plethico
), to purchase all outstanding shares of common stock, $.01 par value per (
Shares
), of Natrol, Inc., a
Delaware corporation, (
Natrol
) at a price of $4.40 per Share, net to the seller in cash, without interest thereon and less any required withholding taxes, upon the terms and subject to the conditions set forth in the Offer to
Purchase dated November 27, 2007 (as it may be amended or supplemented from time to time, the
Offer to Purchase
) and in the related Letter of Transmittal (as it may be amended or supplemented from time to time, the
Letter of Transmittal
and, together with the Offer to Purchase, the
Offer
), which are annexed to and filed with this Schedule TO as Exhibits (a)(1)(A) and (a)(1)(B), respectively. This Schedule TO is being filed
on behalf of Purchaser and Plethico. Unless otherwise indicated, references to sections in this Schedule TO are references to sections of the Offer to Purchase. The Agreement and Plan of Merger, dated as of November 18, 2007 (as it may be
amended or supplemented from time to time, the
Merger Agreement
), by and among Natrol, a Delaware corporation, Plethico, a public limited company incorporated under the laws of India and indirect parent of Purchaser, and
Purchaser, a copy of which is attached as Exhibit (d)(1) hereto is incorporated herein by reference with respect to Items 4 through 11 of this Schedule TO.
Item 1.
Summary Term Sheet.
The information set forth in the Summary Term Sheet in the
Offer to Purchase is incorporated herein by reference.
Item 2.
Subject Company Information.
(a) The name of the subject company is Natrol. Natrols principal executive office is located at 21411 Prairie Street, Chatsworth, California 91311,
and its telephone number at such principal executive office is (818) 739-6000.
(b) This Tender Offer Statement on Schedule TO relates
to Purchasers offer to purchase all outstanding Shares. According to Natrol, as of November 14, 2007, there were 14,261,944 Shares issued and outstanding, as represented by Natrol in the Merger Agreement.
(c) The information set forth in Section 6Price Range of Shares; Dividends of the Offer to Purchase is incorporated herein by
reference.
Item 3.
Identity and Background of Filing Person.
The information set forth in Section 9Certain Information Concerning Purchaser and Plethico and Schedule A to the Offer to Purchase
is incorporated herein by reference.
Item 4.
Terms of the Transaction.
The information set forth in the Offer to Purchase is incorporated herein by reference.
Item 5.
Past Contacts, Transactions, Negotiations and Agreements.
The
information set forth in Sections 8, 9, 10 and 11Certain Information Concerning Natrol, Certain Information Concerning Purchaser and Plethico, Background of the Offer; Contacts with Natrol and Purpose
of the Offer and Plans for Natrol; Summary of the Merger Agreement of the Offer to Purchase is incorporated herein by reference.
Item 6.
Purposes of the Transaction and Plans or Proposals.
The information set forth in Sections 6, 7, 10, 11 and
14Price Range of Shares; Dividends, Possible Effects of the Offer on the Market for the Shares; Nasdaq Listing; Exchange Act Registration and Margin
2
Regulations, Background of the Offer; Contacts with Natrol, Purpose of the Offer and Plans for Natrol; Summary of the Merger
Agreement and Dividends and Distributions of the Offer to Purchase is incorporated herein by reference.
Item 7.
Source
and Amount of Funds or Other Consideration.
The information set forth in Section 12Source and Amount of
Funds of the Offer to Purchase is incorporated herein by reference.
Item 8.
Interest in Securities of the Subject Company.
The information set forth in Sections 8, 9, 10 and 11Certain Information Concerning Natrol, Certain
Information Concerning Purchaser and Plethico, Background of the Offer; Contacts with Natrol and Purpose of the Offer and Plans for Natrol; Summary of the Merger Agreement of the Offer to Purchase is incorporated herein
by reference.
Item 9.
Persons/Assets, Retained, Employed, Compensated or Used.
The information set forth in Sections 10, 11 and 16Background of the Offer; Contacts with Natrol, Purpose of the Offer and Plans
for Natrol; Summary of the Merger Agreement and Fees and Expenses of the Offer to Purchase is incorporated herein by reference.
Item 10.
Financial Statements.
Not applicable.
Item 11.
Additional Information.
(a)(1) The information set forth in Sections 8, 9, 10 and 13Certain Information Concerning Purchaser and Plethico, Background of the Offer; Contacts with Natrol, Purpose of the Offer and Plans for Natrol;
Summary of the Merger Agreement and Conditions of the Offer of the Offer to Purchase is incorporated herein by reference.
(a)(2),(3) The information set forth in Sections 11, 13 and 15Purpose of the Offer and Plans for Natrol; Merger Agreement, Conditions of the Offer and Certain Legal Matters of the Offer to Purchase
is incorporated herein by reference.
(a)(4) The information set forth in Section 7Possible Effects of the Offer on the
Market for the Shares; Nasdaq Listing; Exchange Act Registration and Margin Regulations of the Offer to Purchase is incorporated herein by reference.
(a)(5) Not applicable.
3
Item 12.
Exhibits.
|
|
|
(a)(1)(A)
|
|
Offer to Purchase, dated November 27, 2007
|
|
|
(a)(1)(B)
|
|
Form of Letter of Transmittal
|
|
|
(a)(1)(C)
|
|
Form of Notice of Guaranteed Delivery
|
|
|
(a)(1)(D)
|
|
Form of Letter to Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees
|
|
|
(a)(1)(E)
|
|
Form of Letter to Clients for Use by Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees
|
|
|
(a)(1)(F)
|
|
Not applicable
|
|
|
(a)(1)(G)
|
|
Internal Revenue Service Form W-9 (Request for Taxpayer Identification Number and Certification), including instructions for completing the form
|
|
|
(a)(1)(H)
|
|
Text of press release issued by Natrol, dated November 18, 2007 (incorporated by reference to Form 14 D-9 filed by Natrol and Purchaser with the Securities and Exchange Commission on
November 27, 2007)
|
|
|
(a)(1)(I)
|
|
Form of summary advertisement, published November 27, 2007 in the New York Times
|
|
|
(a)(2)
|
|
Not applicable
|
|
|
(a)(3)
|
|
Not applicable
|
|
|
(a)(4)
|
|
Not applicable
|
|
|
(a)(5)
|
|
Not applicable
|
|
|
(d)(1)
|
|
Agreement and Plan of Merger, dated as of November 18, 2007, by and among Natrol,
Plethico, and Nutra Acquisition Company, Inc.
|
|
|
(d)(2)
|
|
Confidentiality Agreement, dated as of July 26, 2007, by and between Plethico and Natrol.
|
|
|
(g)
|
|
Not applicable
|
|
|
(h)
|
|
Not applicable
|
Item 13.
Information Required by Schedule 13E-3.
Not applicable.
4
SIGNATURE
After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
Nutra Acquisition Company, Inc.
|
|
|
By:
|
|
/s/ D
R
. M
ANMOHAN
A. P
ATEL
|
|
|
Name: Dr. Manmohan A. Patel
|
|
|
Title: Treasurer & Secretary
|
|
Plethico
|
|
|
By:
|
|
/s/ S
ANJAY
P
AI
|
|
|
Name: Sanjay Pai
|
|
|
Title: Chief Finance Officer
|
Dated: November 27, 2007
5
EXHIBIT INDEX
|
|
|
(a)(1)(A)
|
|
Offer to Purchase, dated November 27, 2007
|
|
|
(a)(1)(B)
|
|
Form of Letter of Transmittal
|
|
|
(a)(1)(C)
|
|
Form of Notice of Guaranteed Delivery
|
|
|
(a)(1)(D)
|
|
Form of Letter to Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees
|
|
|
(a)(1)(E)
|
|
Form of Letter to Clients for Use by Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees
|
|
|
(a)(1)(F)
|
|
Not applicable
|
|
|
(a)(1)(G)
|
|
Internal Revenue Service Form W-9 (Request for Taxpayer Identification Number and Certification), including instructions for completing the form
|
|
|
(a)(1)(H)
|
|
Text of press release issued by Natrol, dated November 18, 2007 (incorporated by reference to Form 14 D-9 filed by Natrol and Purchaser with the Securities and Exchange Commission on
November 18, 2007)
|
|
|
(a)(1)(I)
|
|
Form of summary advertisement, published November 27, 2007 in the New York Times
|
|
|
(a)(2)
|
|
Not applicable
|
|
|
(a)(3)
|
|
Not applicable
|
|
|
(a)(4)
|
|
Not applicable
|
|
|
(a)(5)
|
|
Not applicable
|
|
|
(d)(1)
|
|
Agreement and Plan of Merger, dated as of November 18, 2007, by and among Natrol,
Plethico, and Nutra Acquisition Company, Inc.
|
|
|
(d)(2)
|
|
Confidentiality Agreement, dated as of July 26, 2007, by and between Plethico and Natrol.
|
|
|
(g)
|
|
Not applicable
|
|
|
(h)
|
|
Not applicable
|
6
Grafico Azioni Natrol (NASDAQ:NTOL)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Natrol (NASDAQ:NTOL)
Storico
Da Dic 2023 a Dic 2024